US new drug launch prices dip slightly but remain high; median net price up 35% since 2022

STAT analysis finds median net launch price for 202 new medicines rose 35% to $257,000 in 2025 from $173,000 in 2022, though prices dipped slightly last year. The trend underscores persistent high launch pricing despite policy scrutiny, with implications for payer budgets and patient access.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works